Exercise and Cardiac Stunning During HD
Trial of Intradialytic Cycling as Kidney Exercise Rehabilitation for Cardiac Stunning in Hemodialysis (TICKERS-HD)
1 other identifier
interventional
160
2 countries
6
Brief Summary
The purpose of this study is to determine the effect of a 12-week cycling during hemodialysis program on hemodialysis-induced myocardial stunning in adult individuals receiving hemodialysis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2023
Typical duration for not_applicable
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 3, 2021
CompletedFirst Posted
Study publicly available on registry
May 7, 2021
CompletedStudy Start
First participant enrolled
March 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2026
CompletedNovember 20, 2025
November 1, 2025
2.8 years
May 3, 2021
November 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in number of cardiac RWMA at peak hemodialysis stress (last 30 min HD) from baseline to 12 weeks measured using echocardiography
Using standard left ventricular apical 2-, 3-, and 4-chamber views and left ventricular parasternal short-axis views collected by the same trained operator at each site 3 times during the mid-week hemodialysis session at each assessment time point as follows: baseline (pre hemodialysis), post-cycling exercise (or mid-dialysis in controls) and at peak hemodialysis stress (\~30 min prior to end of hemodialysis). Echocardiogram image analysis will be performed in London, ON using automated speckle-tracking analysis (EchoPAC-PC software version 110.1.3; GE Healthcare).
Baseline to 12 weeks
Secondary Outcomes (16)
Change in post-hemodialysis high sensitivity Troponin T level from baseline to 12 weeks
Baseline to 12 weeks
Change in difference between pre-hemodialysis and post-hemodialysis Troponin T from baseline to 12 weeks
Baseline to 12 weeks
Change in number of cardiac RWMA at peak hemodialysis stress (last 30 min HD) from baseline to 16 weeks measured using echocardiography
Baseline to 16 weeks
Change in severity of post-hemodialysis fatigue
Baseline to 12 weeks
Change in Symptom Burden
Baseline to 12 weeks
- +11 more secondary outcomes
Study Arms (2)
Exercise (Intradialytic Cycling)
EXPERIMENTALParticipants will receive a standardized baseline exercise counseling session as per control and then participate in a supervised intradialytic cycling program for 12-weeks
Usual Care
NO INTERVENTIONParticipants will receive a standardized baseline exercise counseling session. Participants in the control group will not undergo formal exercise intervention, but will not be prohibited from participating in exercise outside of hemodialysis. They will be asked to not to participate in intradialytic cycling during the study (16 weeks total).
Interventions
This intervention will consist of intradialytic cycling for 60 minutes 3 times per week for a total of 12 weeks.
Eligibility Criteria
You may qualify if:
- Adults greater than or equal to 18 years old (no upper age limit); who are greater than; 3 months after starting maintenance hemodialysis
- No expected change in dialysis modality, elective surgery or relocation outside of study site during the intervention period (16 weeks)
- Assessed to be safe and able to exercise by the hemodialysis unit nephrologist
- Able to communicate in English and provide written informed consent
- Must be dialyzing thrice weekly
You may not qualify if:
- Acute coronary syndrome in the past 3 months
- Unstable arrhythmia
- Shortness of breath at rest or with minimal activity (NYHA Class 4)
- Symptomatic hypoglycemia (\>2x/week in week prior to enrolment)
- Participating in clinical intradialytic cycling program in last 3 months (if a clinical program exists)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (6)
University of South Australia
Adelaide, South Australia, 5001, Australia
University of Calgary Cumming School of Medicine Department of Internal Medicine
Calgary, Alberta, T2N 2T9, Canada
University of Alberta Department of Internal Medicine
Edmonton, Alberta, T6G 2G3, Canada
St. Pauls Hospital
Vancouver, British Columbia, V6Z1Y6, Canada
University of Manitoba Department of Internal Medicine
Winnipeg, Manitoba, R3A 1R9, Canada
Western University
London, Ontario, N6A5C1, Canada
Related Publications (2)
Bennett PN, Penny JD, McIntyre CW, Vanderlinden J, Borkum MS, Castillo G, Collister D, Corradetti B, Duhamel TA, Farion H, Ford E, Garcia E, Getachew R, Jesudason S, Kiaii M, Leu RL, Presseau J, Rigatto C, Seitz AK, Shirazi M, Soni A, Stewart K, Tarca B, Tennankore K, Verdin N, Whitlock R, Wilund K, Thompson S, MacRae JM, Bohm C. Randomized Controlled Trial of Intradialytic Cycling as Kidney Exercise Rehabilitation for Cardiac Stunning in Hemodialysis (TICKERS_HD): A Clinical Research Protocol. Can J Kidney Health Dis. 2026 Jan 17;13:20543581251391112. doi: 10.1177/20543581251391112. eCollection 2026.
PMID: 41555861DERIVEDMcIntyre CW. Update on Hemodialysis-Induced Multiorgan Ischemia: Brains and Beyond. J Am Soc Nephrol. 2024 May 1;35(5):653-664. doi: 10.1681/ASN.0000000000000299. Epub 2024 Jan 26.
PMID: 38273436DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Clara Bohm, MD, MPH
University of Manitoba
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Data analysts will also be blinded to study group
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 3, 2021
First Posted
May 7, 2021
Study Start
March 1, 2023
Primary Completion
January 1, 2026
Study Completion
March 1, 2026
Last Updated
November 20, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share